Ftse Mib
33.394,95
-0,93%
DAX
18.063,24
-0,55%
S&P 500
5.469,30
0,00%
NASDAQ
17.717,65
0,00%
Bitcoin
61.380,01
-0,70%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ikena Oncology Inc (IKNA) Ikena Oncology Inc (IKNA) Notizie

IKNA

Ikena Oncology (IKNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IKNA
DataOraFonteTitoloSimboloCompagnia
10/06/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202422:42GlobeNewswire Inc.UPDATE – Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
28/05/202422:15GlobeNewswire Inc.Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202422:45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202422:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202414:00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202413:00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
05/03/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
05/03/202422:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
27/02/202414:00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
21/02/202422:15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
18/01/202422:05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202313:00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
07/11/202314:00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
25/09/202322:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
15/09/202322:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
12/09/202322:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
11/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202314:00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
18/08/202322:03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
18/08/202322:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202314:00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
07/08/202313:00GlobeNewswire Inc.Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock TransactionNASDAQ:IKNAIkena Oncology Inc
13/06/202322:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IKNAIkena Oncology Inc
09/06/202322:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IKNAIkena Oncology Inc
24/05/202314:00GlobeNewswire Inc.Ikena Oncology to Participate in Upcoming Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
15/05/202313:50GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology PipelineNASDAQ:IKNAIkena Oncology Inc
15/05/202313:45GlobeNewswire Inc.Ikena Oncology Announces $40 Million Underwritten OfferingNASDAQ:IKNAIkena Oncology Inc
15/05/202313:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IKNAIkena Oncology Inc
15/05/202312:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IKNAIkena Oncology Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IKNA

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
SRG
Snam
BIT
LDO
Leonardo
BIT
G
Generali
BIT
FCT
Fincantieri
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network